New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
07:56 EDTGGenpact secondary risk is minimal, says RW Baird
Baird expects shares of Genpact to be weak following its announcement of a secondary offering. The firm believes the ongoing secondary risk is minimal and views the company risk/reward as favorable citing its strong management team, execution, and potential upside to Q4 estimates. Shares are Outperform rated with a $20 price target.
News For G From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
16:08 EDTGGenpact boosts share repurchase program by $250M to $500M
Subscribe for More Information
16:07 EDTGGenpact sees 2016 adjusted EPS $1.40-$1.42, consensus $1.39
Subscribe for More Information
16:06 EDTGGenpact reports Q4 adjusted EPS 34c, consensus 31c
Subscribe for More Information
08:10 EDTGNASCO and Genpact announces partnership to reimagine US healthcare
NASCO and Genpact announced they will partner in an innovative effort to address the business operations needs of healthcare plans in the continually evolving U.S. healthcare market. NASCO and Genpact will transform health plan administration into a digitally-powered operating model that surrounds and extends NASCO's established, extremely efficient and scalable technology platform.
February 2, 2016
11:18 EDTGGenpact management to meet with Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use